Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment
Clinical infectious diseases/Clinical infectious diseases (Online. University of Chicago. Press)